welcome

We are glad to welcome you to our website

Variable Selection and Model Construction. Model Selection and Parameter Estimation. Regional Brain Atrophy Analysis. For regional mediation analysis, we employed the same methodology as explained above (Multivariate Analysis).

Code and Material Availability. ResultsMultivariate Analysis: Simvastatin Effect on Clinical Outcomes and Brain Atrophy Is Independent of Cholesterol. The Bayesian Analysis: Simvastatin Effects on Clinical Outcomes Are Independent of Cholesterol and Are Partially Mediated by Brain Atrophy.

The Effect of Simvastatin on Brain Atrophy Was Predominant on the Lateral Ventricles and Transverse Temporal Gyrus. DiscussionWe used multivariate structural equation models to explore and test hypothesized causal mechanisms that may explain the observed treatment effect of a potential neuroprotective drug using the simvastatin trial as a model.

AcknowledgmentsWe gratefully acknowledge Prof. This article is a PNAS Direct Submission. OpenUrlChataway J, et al. OpenUrlCrossRefPubMedMarrie RA, et al. OpenUrlCrossRefPubMedBollen KA, Long JS (1992) Tests for structural equation models: Introduction.

OpenUrlCrossRefDouaud G, et al. OpenUrlCrossRefPubMedImai K, Keele L, Tingley D, Yamamoto T (2011) Unpacking the black box of causality: Learning about causal mechanisms from experimental and observational studies. OpenUrlCrossRefChan D, et al. OpenUrlKurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS).

OpenUrlCrossRefPubMedPolman CH, et al. OpenUrlCrossRefPubMedHobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The multiple sclerosis impact scale (MSIS-29): A new patient-based outcome measure.

OpenUrlCrossRefPubMedWechsler D (2011) Wechsler Abbreviated Scale of Intelligence (Pearson, San Antonio, TX), 2nd Ed. Gronwall DMA (1977) Paced auditory serial-addition task: A measure of recovery from concussion. OpenUrlCrossRefPubMedDubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: A frontal assessment battery at bedside. OpenUrlCrossRefPubMedMAGNIMS Study GroupEshaghi A, et al.

OpenUrlCrossRefPubMedSmith SM, De Stefano N, Jenkinson M, Matthews PM (2001) Normalized accurate measurement of longitudinal brain change. OpenUrlCrossRefPubMedTustison NJ, et al. OpenUrlCrossRefPubMedReuter M, Fischl B (2011) Avoiding asymmetry-induced bias in longitudinal image processing. OpenUrlCrossRefPubMedSudre CH, et al. OpenUrlCarass A, et al. OpenUrlCrossRefPubMedPrados F, et al. OpenUrlCardoso MJ, et al. OpenUrlCrossRefPubMedKlein A, Tourville J (2012) 101 labeled brain images and a consistent human cortical labeling protocol.

OpenUrlCrossRefPubMedRosseel Y (2012) lavaan : An R package for structural equation modeling. OpenUrlCrossRefBosma LV, Sonder JM, Kragt JJ, Polman CH, Uitdehaag BM (2015) Detecting clinically-relevant changes in progressive multiple sclerosis. OpenUrlCrossRefPubMedLarochelle C, Uphaus T, Prat A, Zipp F (2016) Secondary progression in multiple sclerosis: Neuronal exhaustion or distinct pathology. OpenUrlCrossRefPubMedHu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives.

OpenUrlCrossRefWagenmakers E-J, Farrell S (2004) AIC model selection using Akaike weights. OpenUrlCrossRefPubMedHartung J, Cottrell JE, Giffin JP (1983) Absence of evidence is not evidence of absence. OpenUrlPubMedAltman DG, Bland JM (1995) Absence of evidence is not evidence of absence.

OpenUrlFREE Full TextMerkle EC, Rosseel Y (2015) blavaan: Bayesian structural equation models via parameter expansion. Preprint, posted November 17, 2016. R Core Team (2014) R: A Language and Environment for Statistical Computing, version 3.

Carpenter B, et al. OpenUrlCrossRefPubMedMalone IB, et al. OpenUrlCrossRefPubMedBenjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing.

OpenUrlCrossRefPubMedZhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M (2016) Cholesterol and markers of cholesterol turnover in multiple sclerosis: Relationship with disease outcomes. OpenUrlCrossRefPubMedGafson AR, et al. OpenUrlGreenwood J, Mason JC (2007) Statins and the vascular endothelial inflammatory response.

OpenUrlCrossRefPubMedOstrowski SM, et al. OpenUrlSaher G, Quintes S, Nave K-A (2011) Cholesterol: A novel regulatory role in myelin formation. OpenUrlCrossRefPubMedHubler Z, et al. OpenUrlCrossRefPubMedMiron VE, et al. OpenUrlCrossRefPubMedMarrie RA (2017) Comorbidity in multiple sclerosis: Implications for patient care. OpenUrlWeitz-Schmidt G, et al. OpenUrlCrossRefPubMedYoussef S, et al. OpenUrlCrossRefPubMedGreenwood J, et al. OpenUrlCrossRefPubMedDunn SE, et al.

OpenUrlCrossRefPubMedJosephs KA, et al. OpenUrlHenneman WJP, et al. OpenUrlCrossRefPubMedLiptak Z, et al. OpenUrlMorosan P, et al. OpenUrlCrossRefPubMedFrischer JM, et al. OpenUrlCrossRefPubMedOLYMPUS Trial GroupHawker K, et al. OpenUrlCrossRefPubMedCarassiti D, et al.

OpenUrlORATORIO Clinical InvestigatorsMontalban X, et al.